Congo-Kinshasa: Vaccinating Against Ebola - the Challenges of Containing the Outbreak

press release

Esther only winces slightly when a doctor on Doctors Without Borders/Médecins Sans Frontières' (MSF) vaccination team injects the Ebola vaccine called rVSV-ZEBOV into her left upper arm in Kimbangu, a community in the southwest of Beni--one of the recurring hotspots of the current Ebola epidemic in North Kivu province of the Democratic Republic of Congo (DRC). Justin*, her two-and-a-half year-old son, bursts into tears when he sees a new syringe being filled, and only calms down a few minutes after receiving his shot. The vaccine feels painful in their arms, but side effects are mostly mild and early results show the vaccine provides effective protection for a promising 95 percent of participants after ten days.

For more than a year, the outbreak response has been in full swing in the city. On site since the early days of the epidemic, the international medical humanitarian organization, MSF, has recently started supporting vaccination activities in Beni as it is a promising tool in the fight against the deadly virus. Yet reaching the right people in a timely manner is a complex endeavor.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.